Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Apposite makes Hollowood a star

This article was originally published in Scrip

Executive Summary

Apposite Capital, specialist healthcare investment firm, has promoted Dr Chris Hollowood to partner. Dr Hollowood joined Apposite in 2007 and has been managing some of the firm's primary investments as well as establishing its direct secondary activities, an area it plans to expand. He is currently a member of the board of directors of Anaphore, Convergence Pharmaceuticals and Zonare Medical Systems. Previously, Dr Hollowood was a fund manager with Neptune Management, with responsibility for Healthcare sector investments, before moving into healthcare focused venture capital and corporate advisory at Bioscience Managers.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts